Global Surgical Hemostatic Agents Market by Player, Region, Type, Application and Sales Channel
- Report Code : MAR2748617
- Published On: Apr, 2023
- Category : Healthcare & Pharma
- Pages : 107
-
This report studies the Surgical Hemostatic Agents market, covering market size for segment by type (Thrombin Hemostats, Oxidized Regenerated Cellulose Hemostats, etc.), by application (Hospital, Retail, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Johnson & Johnson, Takeda (Corza Health), BD, Baxter, B. Braun, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Surgical Hemostatic Agents from 2017-2022, and provides extensive market forecasts from 2023-2031 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Surgical Hemostatic Agents market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Surgical Hemostatic Agents including:
Johnson & Johnson
Takeda (Corza Health)
BD
Baxter
B. Braun
Pfizer
Teleflex
Medtronic
Integra LifeSciences
Ferrosan Medical Devices
GELITA
Advanced Medical Solutions
Medtrade Products
Marine Polymer Technologies
curasan AG
Betatech Medical
Equimedical
Market split by Type, can be divided into:
Thrombin Hemostats
Oxidized Regenerated Cellulose Hemostats
Combination Hemostats
Gelatin Hemostats
Collagen Hemostats
Market split by Application, can be divided into:
Hospital
Retail
Government/Military
Others
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
-
With tables and figures helping analyze worldwide Global Surgical Hemostatic Agents market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Chapter 1 Surgical Hemostatic Agents Market Overview1.1 Surgical Hemostatic Agents Definition
1.2 Global Surgical Hemostatic Agents Market Size Status and Outlook (2017-2031)
1.3 Global Surgical Hemostatic Agents Market Size Comparison by Region (2017-2031)
1.4 Global Surgical Hemostatic Agents Market Size Comparison by Type (2017-2031)
1.5 Global Surgical Hemostatic Agents Market Size Comparison by Application (2017-2031)
1.6 Global Surgical Hemostatic Agents Market Size Comparison by Sales Channel (2017-2031)
1.7 Surgical Hemostatic Agents Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 Surgical Hemostatic Agents Market Segment Analysis by Player2.1 Global Surgical Hemostatic Agents Sales and Market Share by Player (2020-2022)
2.2 Global Surgical Hemostatic Agents Revenue and Market Share by Player (2020-2022)
2.3 Global Surgical Hemostatic Agents Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Surgical Hemostatic Agents Market Segment Analysis by Type3.1 Global Surgical Hemostatic Agents Market by Type
3.1.1 Thrombin Hemostats
3.1.2 Oxidized Regenerated Cellulose Hemostats
3.1.3 Combination Hemostats
3.1.4 Gelatin Hemostats
3.1.5 Collagen Hemostats3.2 Global Surgical Hemostatic Agents Sales and Market Share by Type (2017-2022)
3.3 Global Surgical Hemostatic Agents Revenue and Market Share by Type (2017-2022)
3.4 Global Surgical Hemostatic Agents Average Price by Type (2017-2022)
3.5 Leading Players of Surgical Hemostatic Agents by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 Surgical Hemostatic Agents Market Segment Analysis by Application4.1 Global Surgical Hemostatic Agents Market by Application
4.1.1 Hospital
4.1.2 Retail
4.1.3 Government/Military
4.1.4 Others4.2 Global Surgical Hemostatic Agents Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of Surgical Hemostatic Agents by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 Surgical Hemostatic Agents Market Segment Analysis by Sales Channel5.1 Global Surgical Hemostatic Agents Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel5.2 Global Surgical Hemostatic Agents Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of Surgical Hemostatic Agents by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Surgical Hemostatic Agents Market Segment Analysis by Region6.1 Global Surgical Hemostatic Agents Market Size and CAGR by Region (2017-2031)
6.2 Global Surgical Hemostatic Agents Sales and Market Share by Region (2017-2022)
6.3 Global Surgical Hemostatic Agents Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Surgical Hemostatic Agents Market Share by Type
6.4.3 North America Surgical Hemostatic Agents Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Surgical Hemostatic Agents Market Share by Type
6.5.3 Europe Surgical Hemostatic Agents Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Surgical Hemostatic Agents Market Share by Type
6.6.3 Asia-Pacific Surgical Hemostatic Agents Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Surgical Hemostatic Agents Market Share by Type
6.7.3 South America Surgical Hemostatic Agents Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Surgical Hemostatic Agents Market Share by Type
6.8.3 Middle East & Africa Surgical Hemostatic Agents Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Surgical Hemostatic Agents Players7.1 Johnson & Johnson
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)7.2 Takeda (Corza Health)
7.3 BD
7.4 Baxter
7.5 B. Braun
7.6 Pfizer
7.7 Teleflex
7.8 Medtronic
7.9 Integra LifeSciences7.10 Ferrosan Medical Devices
7.11 GELITA
7.12 Advanced Medical Solutions
7.13 Medtrade Products
7.14 Marine Polymer Technologies
7.15 curasan AG
7.16 Betatech Medical
7.17 Equimedical
Chapter 8 Upstream and Downstream Analysis of Surgical Hemostatic Agents8.1 Industrial Chain of Surgical Hemostatic Agents
8.2 Upstream of Surgical Hemostatic Agents
8.3 Downstream of Surgical Hemostatic Agents
Chapter 9 Development Trend of Surgical Hemostatic Agents (2023-2031)9.1 Global Surgical Hemostatic Agents Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global Surgical Hemostatic Agents Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global Surgical Hemostatic Agents Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global Surgical Hemostatic Agents Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global Surgical Hemostatic Agents Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
-
The Global Surgical Hemostatic Agents Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
The Global Surgical Hemostatic Agents study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.
Depending upon the type of applications, the Global Surgical Hemostatic Agents Market has been segmented into
According to the report, the Global Surgical Hemostatic Agents Industry will grow to USD XXX Million by 2029, with a YY% CAGR.
The influx of capital into the Global Surgical Hemostatic Agents Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
The Global Surgical Hemostatic Agents Market is expected to reach a considerable market valuation.